Actively Recruiting

Age: 18Years +
All Genders
ID07445412

Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy - IGROWtoh

Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2026-03-03

2000

Participants Needed

1

Research Sites

26 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is an observational research project conducted across multiple centers in Italy to understand and describe changes over time in the use of techniques for inducing liver growth (hepatic hypertrophy). It focuses on patients with liver tumors or cancer who require liver surgery but have a future liver remnant volume considered too small by their medical teams. The goal is to compare and understand different methods used over recent years to help guide treatment decisions. Participants are observed according to the usual care practices at their treatment centers. The study includes two groups: a prospective group followed from recruitment and observed for up to five years after liver surgery to record health events, and a retrospective group made up of patients treated with these hypertrophy techniques in the past ten years. This historical data will be used to compare with the new patient group to better understand trends and outcomes. Throughout the study, information about patients' health status, including survival and disease progression, will be collected regularly. Researchers will track various outcomes such as liver function, growth in liver volume, dropout rates from treatment, short-term mortality within 90 days, long-term survival, and disease-free survival. This comprehensive follow-up helps to evaluate the effectiveness and safety of the different hypertrophy techniques used in clinical practice in Italy.

CONDITIONS

Brief Title

Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 18 or older
  • Provided informed consent
  • Diagnosed with liver neoplasia (benign or malignant)
  • Future liver remnant volume considered insufficient (less than 20%-40%) by local multidisciplinary team
Not Eligible

You will not qualify if you...

  • Pregnant or breastfeeding women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 5 years

Participants who underwent hepatic hypertrophy techniques are observed to record clinical events, outcomes, and survival for up to 5 years after surgery.

Periodic visits as determined by treating centers

Trial Site Locations

Total: 1 location

1

IRCCS Azienda Ospedaliero-Universitario di Bologna

Bologna, Bologna, Italy, 401328

Actively Recruiting

Loading map...

Research Team

E

Elio Jovine, MD

M

Matteo Serenari, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Intra-procedural Spectral CT for Image-guided Embolization a...

Liver Cancer (Primary and Metastatic)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here